Veeva Systems Inc. (VEEV) AI Stock Analysis
VEEV AI stock analysis summary
AI ResearchVeeva Systems Inc. provides cloud software, data, and analytics solutions for the global life sciences industry. The company generated $3.46B in trailing twelve-month revenue with a 29.3% profit margin and holds $7.09B in net cash as of July 31, 2026. While its stock gained 39.0% year-to-date, its trailing P/E of 50.9x trades well above the S&P 500 Healthcare peer median of 27.2x.
- Market cap
- $50.25B
- Revenue (TTM)
- $3.46B
- P/E
- 50.9x fwd 30.2x
- 1Y return
- 6.0% S&P 500 16.8%
- Avg. target
- $297.04 -4.3% vs last close
Bull case
- Veeva delivered strong FY2026 free cash flow of $1.39B, supported by an operating cash flow of $1.42B and low capital expenditures of $29.1M.
- Profitability is high, with a trailing twelve-month profit margin of 29.3% and quarterly earnings growth of 39.5% for the period ended July 31, 2026.
- The balance sheet exhibits substantial liquidity, holding $7.09B in net cash and a low debt-to-equity ratio of 0.02 as of July 31, 2026.
Bear case
- Valuation multiples are elevated compared to peers, with a trailing P/E of 50.9x versus the S&P 500 Healthcare peer median of 27.2x.
- The consensus mean price target of $297.04 represents a 4.3% discount to the last close of $310.36.
- Long-term share performance has trailed broader markets, posting a 5-year return of 0.3% compared to an 83.0% gain for the S&P 500.
What Veeva does
Veeva Systems Inc. provides cloud-based software solutions tailored for the life sciences industry across North America, Europe, Asia Pacific, Middle East, Africa, and Latin America. Its offerings include Veeva Commercial Cloud, featuring software, data, and analytics applications like Veeva CRM, Veeva Align, and Veeva Data Cloud. The company also offers Veeva Vault, a cloud platform for enterprise content and data management supporting commercial functions and research and development operations across clinical, regulatory, quality, and safety areas. In addition, Veeva provides professional services such as implementation, deployment planning, and ongoing managed services.
Growth and profitability
Veeva increased annual revenue from $1.85B in FY2022 to $3.20B in FY2026, delivering a 5-year revenue CAGR of 16.9%. Over the same span, net income expanded from $427.4M to $908.9M, while EPS grew from $3.72 to $8.06. Gross margin rose from 72.8% in FY2022 to 75.5% in FY2026, and operating margin improved from 27.3% to 28.7%. In the trailing twelve months ended July 31, 2026, revenue reached $3.46B with a profit margin of 29.3%. In the latest quarter ended July 31, 2026, quarterly revenue grew 17.6% year-over-year, while quarterly earnings surged 39.5%.
Balance sheet and cash flow
As of July 31, 2026, Veeva held $7.24B in cash and short-term investments against total debt of $151.7M, resulting in net cash of $7.09B. The company maintained a debt-to-equity ratio of 0.02 and a current ratio of 5.46. Total assets stood at $9.06B compared to shareholders' equity of $7.43B. In FY2026, Veeva generated $1.42B in operating cash flow and $1.39B in free cash flow. Capital expenditures were $29.1M, and the company allocated $169.9M toward share buybacks.
Valuation and performance
Veeva trades at a trailing P/E of 50.9x and a forward P/E of 30.2x, compared to the median of its S&P 500 Healthcare peers of 27.2x and 16.5x, respectively. Its price-to-sales multiple is 14.5x versus the peer median of 3.4x, and EV-to-EBITDA stands at 34.2x against the peer median of 15.0x. The company's enterprise value is $36.75B and its PEG ratio is 1.21. Over the past year, Veeva returned 6.0%, trailing the S&P 500 return of 16.8%. Over five years, the stock returned 0.3% compared to 83.0% for the S&P 500.
What analysts expect
Wall Street sentiment includes 13 Strong Buy, 7 Buy, 8 Hold, 0 Sell, and 1 Strong Sell ratings. The mean price target is $297.04, which is 4.3% below the last close of $310.36. For the current fiscal year ending January 31, 2027, analysts estimate EPS of $9.24 on revenue of $3.69B. For the next fiscal year, 26 analysts project EPS of $10.25 and revenue of $4.14B. Veeva has beaten EPS estimates in each of the last 4 quarters, with its next earnings date scheduled for November 19, 2026.
Key risks and what to watch
- The stock trades at 51.5% above its 200-day average, which may heighten volatility if market sentiment shifts.
- Revenue growth projections show deceleration to 12.3% for the next fiscal year compared to 16.3% achieved in FY2026.
- Elevated valuation metrics like an EV-to-EBITDA of 34.2x leave limited room for execution errors relative to the peer median of 15.0x.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this VEEV AI stock analysis
This page is an AI-written research summary of Veeva Systems Inc. (VEEV). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: VEEV income statement, VEEV balance sheet, VEEV key metrics, VEEV analyst forecast, VEEV chart. See the VEEV stock overview for the latest quote and news.
VEEV AI stock analysis FAQ
What was Veeva's revenue growth in the latest quarter?
In the quarter ended July 31, 2026, Veeva reported year-over-year revenue growth of 17.6% and quarterly earnings growth of 39.5%.
Does Veeva Systems pay a dividend?
Veeva Systems does not pay a dividend, instead using capital for investments such as $169.9M in share buybacks and $29.1M in capital expenditures in FY2026.
How strong is Veeva's balance sheet?
As of July 31, 2026, Veeva held $7.24B in cash and short-term investments against $151.7M in total debt, yielding $7.09B in net cash and a current ratio of 5.46.
What do analysts expect for Veeva's upcoming earnings?
For the fiscal year ending January 31, 2027, analysts forecast EPS of $9.24 on revenue of $3.69B, with the next quarterly report set for November 19, 2026.